AFAO Health Promotion Officer, Ben Wilcock, reports back on the 2nd International HIV/Viral Hepatitis Co-infection Meeting, held in Vancouver.
On Friday and Saturday (17-18 July), I was fortunate to be able to attend the 2nd International HIV/Viral Hepatitis Co-infection Meeting in Vancouver. It was an official event before the IAS Conference on HIV Pathogenesis, Treatment and Prevention (#IAS2015).
There were a range of issues covered relating to HIV and viral hepatitis co-infections (both hepatitis B and C), with a particular focus on building momentum towards expanding hepatitis C treatment access globally for people co-infected with HIV and viral hepatitis, in the light of the new range of direct-acting antiviral (DAA) treatments for hepatitis C now available (though often not yet accessible) and in the pipeline. (See: #ACureForAll for more info).
